(Q49066781)

English

N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumour necrosis factor-alpha in patients referred for consideration of cardiac transplantation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumour necrosis factor-alpha in patients referred for consideration of cardiac transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

0 references

author name string

Roy S Gardner

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

Victor Chong

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

Iain Morton

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

Theresa A McDonagh

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

253-260

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Importance of blockade in the treatment of advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Cardiac secretion of adrenomedullin in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.06.002

21 January 2018

Identifiers

10.1016/J.EJHEART.2004.06.002

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/15701475

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49066781&oldid=1601754565"